HomeCompareMVF vs JNJ

MVF vs JNJ: Dividend Comparison 2026

MVF yields 6.11% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MVF wins by $20.3K in total portfolio value
10 years
MVF
MVF
● Live price
6.11%
Share price
$7.07
Annual div
$0.43
5Y div CAGR
10.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.3K
Annual income
$3,213.36
Full MVF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MVF vs JNJ

📍 MVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MVF
Annual income on $10K today (after 15% tax)
$519.38/yr
After 10yr DRIP, annual income (after tax)
$2,731.36/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MVF beats the other by $2,027.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MVF + JNJ for your $10,000?

MVF: 50%JNJ: 50%
100% JNJ50/50100% MVF
Portfolio after 10yr
$30.2K
Annual income
$2,020.57/yr
Blended yield
6.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MVF
No analyst data
Altman Z
0.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MVF buys
0
JNJ buys
0
No recent congressional trades found for MVF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMVFJNJ
Forward yield6.11%3.36%
Annual dividend / share$0.43$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR10.8%5.8%
Portfolio after 10y$40.3K$20.0K
Annual income after 10y$3,213.36$827.78
Total dividends collected$16.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MVF vs JNJ ($10,000, DRIP)

YearMVF PortfolioMVF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,377$677.02$10,676$355.77+$701.00MVF
2$12,971$797.61$11,407$389.39+$1.6KMVF
3$14,821$941.65$12,198$426.53+$2.6KMVF
4$16,972$1,114.14$13,056$467.62+$3.9KMVF
5$19,481$1,321.19$13,987$513.12+$5.5KMVF
6$22,416$1,570.38$14,998$563.56+$7.4KMVF
7$25,856$1,871.07$16,098$619.52+$9.8KMVF
8$29,900$2,234.87$17,295$681.69+$12.6KMVF
9$34,670$2,676.27$18,599$750.82+$16.1KMVF
10$40,310$3,213.36$20,022$827.78+$20.3KMVF

MVF vs JNJ: Complete Analysis 2026

MVFStock

BlackRock MuniVest Fund, Inc. is a closed-ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in the fixed income markets of the United States. It primarily invests in investment grade, long term municipal obligations that are exempt from federal income taxes. The fund seeks to invest in securities with maturities of more than ten years. BlackRock MuniVest Fund, Inc. was formed on September 29, 1988 and is domiciled in the United States.

Full MVF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MVF vs SCHDMVF vs JEPIMVF vs OMVF vs KOMVF vs MAINMVF vs ABBVMVF vs MRKMVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.